Edimer: Switzerland-based Company successful in the Boston Area
Edimer: Switzerland-based Company successful in the Boston Area
Edimer Biotech S.A. is a Switzerland-based biotechnology start-up that develops therapeutics for treatment of X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED), a genetic disease. The company went through the coaching process of the Innovation Promotion Agency CTI and received the prestigious CTI Start-up ’Label’ in 2009.
We are delighted to announce that recently, the Boston-based venture firm “Third Rock Ventures” financed the U.S. site of the company with Series A financing in the amount of over 20 million dollars. The U.S. company is now located in Kendall Square and company officials say that the funding they got will last through approval of the drug target.
